G. Rolla et al., Exhaled nitric oxide in systemic sclerosis: Relationships with lung involvement and pulmonary hypertension, J RHEUMATOL, 27(7), 2000, pp. 1693-1698
Objective. To measure nitric oxide (NO concentration in exhaled air of pati
ents with systemic sclerosis (SSc) and to investigate its relationships wit
h lung involvement, complicated or not by pulmonary hypertension (PH).
Methods. Exhaled NO was measured by chemiluminescence in 47 patients with S
Sc (16 with PH) and in 30 controls. All the patients underwent Doppler echo
cardiography to assess pulmonary artery pressure (PAP), lung function tests
, and thin section computed tomographic scans of the lung to quantify the e
xtent of fibrosing alveolitis.
Results. Exhaled NO levels were higher in patients with SSc (16.6 +/- 9.1 p
pb), particularly those with interstitial lung disease (ILD) (18.3 +/- 10.4
ppb), compared to controls (9.9 +/- 2.9 ppb; p < 0.0001). In patients with
PH, exhaled NO was less than in patients without PH (10.7 +/- 5.9 vs 19.6
+/- 9 ppb, respectively; p < 0.001), and patients with PH without no had ev
en lower exhaled NO than patients with PH and ILD (6.6 +/- 1.1 vs 12.6 +/-
6.3 ppb; p = 0.004). There was an inverse correlation between PAP and exhal
ed NO (r = -0.53, p = 0.004). Exhaled NO was not correlated to age, disease
duration, current therapy, or form of disease (limited or diffuse).
Conclusion, The increased concentration of exhaled NO in patients with SSc
may reflect respiratory tract inflammation. The relatively low value of exh
aled NO in patients with PH and the negative correlation between PAP and ex
haled NO suggest the important role of NO in regulating pulmonary vascular
resistance in patients with SSc.